Embryonal rhabdomyosarcoma of the urogenital tract in childhood.
18 children, 12 boys and 6 girls, were treated in our hospital for rhabdomyosarcoma of the urogenital tract between 1970 and 1980. This period saw a gradual change in the therapeutic approach to this disease as new therapeutic modalities became available. 7 of the patients (39%) died of the disease which, in 5 of them, arose from the prostate. The surviving children have no evidence of recurrent disease, although 1 is still undergoing chemotherapy. Surgical intervention was always required. To date, chemotherapy alone, or in combination with radiation, has not sufficed in our management of rhabdomyosarcoma of the urogenital tract.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy; D012208:Rhabdomyosarcoma / Q000601:surgery / Q000628:therapy*; D001749:Urinary Bladder Neoplasms / Q000628:therapy; D014565:Urogenital Neoplasms / Q000601:surgery / Q000628:therapy*; D002583:Uterine Cervical Neoplasms / Q000628:therapy; D014625:Vaginal Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents